Linking Up

Biological interactions form the basis for many assays; polyvalent interactions between biomolecules have been used for specific binding, immobilization, and detection. But biological affinity methods can have several drawbacks, including limited reproducibility, high background, low binding capacity, and poor stability. Prolinx Inc. of Bothell, Wash., has introduced Versalinx Chemical Affinity Tools, a synthetic affinity binding pair based on the interaction between phenylboronic acid (PBA) or

Written byAileen Constans
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Biological interactions form the basis for many assays; polyvalent interactions between biomolecules have been used for specific binding, immobilization, and detection. But biological affinity methods can have several drawbacks, including limited reproducibility, high background, low binding capacity, and poor stability. Prolinx Inc. of Bothell, Wash., has introduced Versalinx Chemical Affinity Tools, a synthetic affinity binding pair based on the interaction between phenylboronic acid (PBA) or phenyldiboronic acid (PDBA) and salicylhydroxamic acid (SHA). These small molecules form a stable complex under a wide variety of buffer, salt, detergent, denaturant, and pH conditions and can be exploited for analytical and preparative assays. According to Karin Hughes, director of applications at Prolinx, "The idea is to provide people with tools to mix and match in order to create and design their own assay or purification system."

To accomplish this, Prolinx offers PBA- and PDBA-based nucleic acid and protein modifying reagents, SHA-conjugated solid phase ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies